CLINICAL_TRIALS
trial_result
· 2021-10-12
Clinical Trial Update: Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis [Phase 3]
Summary
Phase 3 trial of benralizumab for severe nasal polyposis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Nasal Polyposis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-12